Reshuffle to let Peptide target US

Peptide Therapeutics, the biotechnology group, is reshuffling its top management team just 15 months after coming to the market. John Brown, a former stockbroker, is moving up from finance director to become chief executive, replacing Alan Goodman, who becomes deputy chairman with a remit to develop the group's North American business. Gordon Cameron, who arrived from merchant bankers NM Rothschild last year, is to become finance director and Nick Higgins moves over from licensing director to commercial director.

Mr Brown described the changes as a realignment of roles. "The largest concentration of our customers are in the US... and we have found that telephone conferences have not been a substitute for having someone on the ground."

Mr Goodman would be targeting "any drug company with a market capitalisation of over $1bn" to sell the group's technology to, Mr Brown said. "He is good at doing deals - that is what turns him on."

The news came as Peptide announced losses for the year to December had grown from pounds 3.61m to pounds 4.59m. But the figures were in line with market expectations and the shares added 2p to 335p yesterday.

The group said its net cash and liquid resources had fallen from pounds 27m to pounds 20.6m during the 12 months, but had since risen to pounds 27.4m after recent alliances with Medeva and SmithKline Beecham. The cash "burn" was on target at pounds 6.4m last year. Research and development expenditure came in at pounds 5m, while capital expenditure was pounds 2m. The group has leased and equipped a further 3,500 square feet of laboratory space in the Cambridge Science Park and has consolidated all operations on one site. Mr Brown said they had "no immediate plans" to raise more money.

The group's main near-term prospect is an allergy vaccine with general applicability, including food allergies, bee stings, juvenile asthma and hay fever. This product, at the centre of the deal with SmithKline, could be attacking a pounds 5bn market by the turn of the century.

But analysts are most excited about Peptide's technology base. The group's RAPiD combinatorial chemistry product provides a new way of developing protease inhibitors, used in the battle against Aids but also a factor in many other diseases. Glaxo Wellcome is thought to be interested in the technology.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
News
ebooksNow available in paperback
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Sheridan Maine: Regulatory Reporting Accountant

Up to £65,000 per annum + benefits: Sheridan Maine: Are you a qualified accoun...

Ashdown Group: Marketing Services Manager - (communications, testing, DM)

£32000 - £35000 per annum + benefits: Ashdown Group: Marketing Services Manage...

Guru Careers: Finance Account Manager

£Neg. (DOE) + Excellent Benefits: Guru Careers: A Finance Account Manager with...

Ashdown Group: Java Developer - Hertfordshire - £47,000 + bonus + benefits

£40000 - £470000 per annum + bonus: Ashdown Group: Java Developer / J2EE Devel...

Day In a Page

Homeless Veterans appeal: 'You look for someone who's an inspiration and try to be like them'

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Could cannabis oil reverse the effects of cancer?

Could cannabis oil reverse effects of cancer?

As a film following six patients receiving the controversial treatment is released, Kate Hilpern uncovers a very slippery issue
The Interview movie review: You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here

The Interview movie review

You can't see Seth Rogen and James Franco's Kim Jong Un assassination film, but you can read about it here
Serial mania has propelled podcasts into the cultural mainstream

How podcasts became mainstream

People have consumed gripping armchair investigation Serial with a relish typically reserved for box-set binges
Jesus Christ has become an unlikely pin-up for hipster marketing companies

Jesus Christ has become an unlikely pin-up

Kevin Lee Light, aka "Jesus", is the newest client of creative agency Mother while rival agency Anomaly has launched Sexy Jesus, depicting the Messiah in a series of Athena-style poses
Rosetta space mission voted most important scientific breakthrough of 2014

A memorable year for science – if not for mice

The most important scientific breakthroughs of 2014
Christmas cocktails to make you merry: From eggnog to Brown Betty and Rum Bumpo

Christmas cocktails to make you merry

Mulled wine is an essential seasonal treat. But now drinkers are rediscovering other traditional festive tipples. Angela Clutton raises a glass to Christmas cocktails
5 best activity trackers

Fitness technology: 5 best activity trackers

Up the ante in your regimen and change the habits of a lifetime with this wearable tech
Paul Scholes column: It's a little-known fact, but I have played one of the seven dwarves

Paul Scholes column

It's a little-known fact, but I have played one of the seven dwarves
Fifa's travelling circus once again steals limelight from real stars

Fifa's travelling circus once again steals limelight from real stars

Club World Cup kicked into the long grass by the continued farce surrounding Blatter, Garcia, Russia and Qatar
Frank Warren column: 2014 – boxing is back and winning new fans

Frank Warren: Boxing is back and winning new fans

2014 proves it's now one of sport's biggest hitters again
Jeb Bush vs Hillary Clinton: The power dynamics of the two first families

Jeb Bush vs Hillary Clinton

Karen Tumulty explores the power dynamics of the two first families
Stockholm is rivalling Silicon Valley with a hotbed of technology start-ups

Stockholm is rivalling Silicon Valley

The Swedish capital is home to two of the most popular video games in the world, as well as thousands of technology start-ups worth hundreds of millions of pounds – and it's all happened since 2009
Did Japanese workers really get their symbols mixed up and display Santa on a crucifix?

Crucified Santa: Urban myth refuses to die

The story goes that Japanese store workers created a life-size effigy of a smiling "Father Kurisumasu" attached to a facsimile of Our Lord's final instrument of torture
Jennifer Saunders and Kate Moss join David Walliams on set for TV adaptation of The Boy in the Dress

The Boy in the Dress: On set with the stars

Walliams' story about a boy who goes to school in a dress will be shown this Christmas